Additionally, increased expression of VEGF-A and -D, as well as reduced expression of the inhibitors VEGFR1 and sVEGFR2, a naturally occurring soluble form of VEGFR2, was observed in MYCN-amplified stage 4 NB [23]. The gene discussed is VEGFA; the disease is neuroblastoma.